# DermBiont

**Canonical:** https://apis.io/providers/dermbiont/  
**Website:** https://www.dermbiont.com/  
**APIs profiled:** 0

DermBiont, Inc. is a Boston, Massachusetts clinical-stage dermatology therapeutics company founded in 2017 that develops targeted topical treatments addressing the root cause of skin disease rather than its symptoms. Its lead program SM-030 is a first-in-class topical PKC-beta inhibitor in development for melasma and other hyperpigmentation disorders of the skin, targeting excess melanin production; earlier programs included SM-020 for seborrheic keratosis and the live-bacterial DBI-001 and DBI-002 candidates for atopic dermatitis, tinea pedis and onychomycosis. The company describes an in-house discovery platform for microbiome-based therapeutics built on terabytes of DNA sequencing data from human skin samples across healthy individuals and patients, paired with a proprietary computational biology platform that identifies functions gained and lost by the skin microbiome. That computational platform is internal research tooling, not a product: DermBiont sells drug candidates and partnering opportunities, publishes no developer program, no public API, no SDK and no machine-readable API contract of any kind, and its website is a Squarespace-hosted corporate site.

## Kin Score — 6.7 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 6.7).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.3 |
| Commercial Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Dermbiont Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Dermatology, Therapeutics, Skin Microbiome, Microbiome, Drug Discovery, Clinical Stage, Life Sciences, Health

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dermbiont/). Scores are computed from the provider's own public artifacts under a published rubric.